In this context, the evidence for a possible involvement of adropin deficiency in the development of AKI during decongestion, via a possible increased susceptibility to metabolic dysregulation, seems promising for optimising diuretic therapy regimens in ADHF. The gene discussed is ENHO; the disease is acute kidney injury.